The Efficacy of the 2023-2024 Updated COVID-19 Vaccines Against COVID-19 Infection

计划入组 1,188 人 · 首次发布于 2023 年 10 月 3 日

Estimated Vaccine Effectiveness and Durability of Pfizer/BioNTech 2024-2025 COVID-19 Vaccine

计划入组 1 人 · 首次发布于 2024 年 11 月 25 日

Impact of Reactogenicity of the 2024-2025 COVID-19 Vaccines on Health Care Workers and First Responders in the United States

计划入组 660 人 · 首次发布于 2024 年 10 月 9 日

mRNA-1273.712

COVID-19 Vaccine, Adjuvanted (Novavax)

COVID-19 Updated Vaccine(Novavax)

E-MO BIOLOGY INC.

United States

BioNTech SE

Germany

AIM VACCINE

China

Novavax COVID-19 Vaccine Targeting JN.1 Authorized for Emergency Use in the U.S.

Novavax's Updated COVID-19 Vaccine Now Available at Major U.S. Pharmacies

Novavax COVID-19 Vaccine Receives FDA Emergency Use Authorization for 2023-2024 Formula